Portola Pharmaceuticals, Inc. Contract Liability (Deferred Revenue)
Portola Pharmaceuticals, Inc. had Contract Liability (Deferred Revenue) of $1.19 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2020-05-11
- 2020-03-31: Contract with Customer, Liability, Current $1.19M.
- 2019-12-31: Contract with Customer, Liability, Current $1.62M.
- 2019-09-30: Contract with Customer, Liability, Current $1.06M.
- 2019-06-30: Contract with Customer, Liability, Current $1.27M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-03-31 | $1.19M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.62M 10-Q · filed 2020-05-11 |
| 2019-09-30 | $1.06M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.27M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.21M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.85M 10-K · filed 2020-02-28 |
| 2018-09-30 | $2.36M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $4.93M 10-Q · filed 2018-08-09 |
| 2018-01-01 | $6.35M 10-K · filed 2019-03-01 |
| 2017-12-31 | $11.17M 10-K · filed 2019-03-01 |